Investment builds on Biogen’s 30-year history of manufacturing in the region, with approximately $10 billion invested to date ...

BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its second quarter 2025 financial ...

(Reuters) -Drugmaker Biogen said on Monday it will invest an additional $2 billion in its existing manufacturing footprint in ...